Poster Abstract Session:
52. C. difficile Epidemiology
Thursday, October 18, 2012: 12:30 PM-2:00 PM
Room: SDCC Poster Hall F-H

Topical Category: N. Infection Epidemiology and Prevention and P. Pediatric and Perinatal Infections

Tracks: Epidemiology and Infection Control, Pediatric ID

Presentations:

338
Incidence and risk factors for Clostridium difficile infections among Medicare beneficiaries: analysis of Chronic Conditions Warehouse data
Matthew Wise, PhD ; Fernanda Lessa, MD ; L. Clifford Mcdonald, MD ; John A. Jernigan, MD, MS

339
Clostridium difficile infections (CDI) among San Francisco County Residents, 2010
Erin P Garcia, MPH, CPH ; Erin Parker, MPH ; Joelle Nadle, MPH ; Lisa Winston, MD
Posters
  • IDSA339.pdf (590.2 kB)

  • 342
    Identification of a Potential Target Population for Primary Prevention of C. difficile Infection through Vaccination
    Ghinwa Dumyati, MD, FSHEA ; Kelly Thevenet-Morrison, MS ; Susan Rhee, MD ; Edwin van Wijngaarden, PhD

    343
    Epidemiology of Clostridium difficile Associated Disease in the United States from 2000-2008
    Karen Krueger, MD ; Geeta Karnik, M.D., M.S. ; Matthew Lee, MD ; Premal Trivedi, MD ; Princy N. Kumar, MD ; Joseph G. Timpone, MD

    344
    Surveillance for Healthcare-associated Clostridium difficile Infection: Laboratory versus Clinical Case Finding
    Diana Montoya-Fontalvo, BS ; E. Yoko Furuya, MD, MS ; Hani Nasrallah, MPH ; Barbara Ross, RN, BSN, CIC ; Lisa Saiman, MD, MPH, FSHEA

    345
    Clostiridium difficile Infections (CDI) in U.S. Department of Veterans Affairs (VA) Medical Centers-Nationwide Trends for Acute Care Hospitalizations
    Stephen Kralovic, MD, MPH ; Loretta Simbartl, MS ; Linda Danko, RN, MSN ; Martin Evans, MD ; Allison Kelly, MD, MSOH ; Marla Clifton, RN, MSN ; Judith Whitlock, RN, MSN ; Shantini Gamage, PhD, MPH ; Rajiv Jain, MD ; Gary Roselle, MD

    347
    Publicly reported rates and laboratory testing methods for Clostridium difficile in California hospitals
    Patricia McLendon, MPH ; Neely Kazerouni, DrPH, MPH ; Kate Cummings, MPH ; Kavita K. Trivedi, MD ; Jon Rosenberg, MD

    348
    The Prevalence of Clostridium difficile in Wuhan China
    Jodi Galaydick, MD ; Emily Landon, MD ; Stephen G. Weber, MD, MS ; Yaqing Xu, MD ; Daiyan Sun ; Junying Zhou ; Lisa Sun ; Renslow Sherer, MD
    Posters
  • Slide1.jpg (137.4 kB)

  • 349
    Dissemination of Multidrug-Resistant Organisms (MDROs) across Statewide Healthcare Facilities
    Rupak Datta, MPH ; Shawn Brown, PhD ; Bruce Y. Lee, MD, MBA ; Susan S. Huang, MD, MPH, FIDSA

    350
    Facility Level Predictors of Publicly Reported Healthcare-Associated Clostridium difficile Infection (HA-CDI) Rates in California Hospitals
    Rupak Datta, MPH ; Jon Rosenberg, MD ; Neely Kazerouni, DrPH, MPH ; Patricia McLendon, MPH ; Kate Cummings, MPH ; Susan S. Huang, MD, MPH, FIDSA

    352
    Risk Factors for the Presence of Clostridium difficile and Acquisition in Children Under 2 years in Oxfordshire, UK
    Nicole Stoesser, BA MBBS ; David Eyre, BM, BCh ; Heather Godwin, MA ; Alison Vaughan, BSc ; Emily Mbuvi, BScN ; Gemma Pill, BSc ; Kaz Wanelik, PhD ; John Finney ; Kate Dingle, PhD ; David Griffiths, BSc ; Lily O'Connor, BSc ; Mark Wilcox, MD ; Tim Peto, MB BS, DPhil ; Derrick Crook, MB, BCh ; A. Sarah Walker, PhD

    353
    Clostridium difficile in Children Below 2 Years of Age: A Systematic Literature Review
    Marc Tebruegge, MD ; Annie Jones, MSc ; Christian Felter, MD ; Ann Pallett, MD ; Saul Faust, MD

    CME Credits:


    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 17th with the exception of research findings presented at the IDWeek press conferences.